Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation

doi:10.12998/wjcc.v10.i28.10004

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3647)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-8) series.

Item

Count

PDF

182

WORD

HTML

2071

Figures (1-2)

267

Tables (1-8)

286

Sum=2840

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

208

Download

563

Sum=771

Oct 6, 2022 (publication date) through May 16, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Oct 6, 2022; 10(28): 10004-10016
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10004

Full Size Figure Download Figure

Figure 2 Autopahgy promotion or inhibition to alleviate diseases and inflammation. AS-IV: Astragaloside IV; T2DM: Type 2 diabetes mellitus.

Citation: Yang Y, Hong M, Lian WW, Chen Z. Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation. World J Clin Cases 2022; 10(28): 10004-10016
URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10004.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10004